Bridgeway Capital Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-198,630
| Closed | -$3.76M | – | 1437 |
|
|
2023
Q1 | $3.76M | Buy |
198,630
+28,730
| +17% | +$543K | 0.1% | 338 |
|
|
2022
Q4 | $3.85M | Hold |
169,900
| – | – | 0.1% | 338 |
|
|
2022
Q3 | $4.49M | Buy |
169,900
+25,000
| +17% | +$661K | 0.12% | 303 |
|
|
2022
Q2 | $3.58M | Buy |
+144,900
| New | +$3.58M | 0.08% | 380 |
|
|
2017
Q3 | – | Sell |
-27,852
| Closed | -$550K | – | 1435 |
|
|
2017
Q2 | $550K | Hold |
27,852
| – | – | 0.01% | 1054 |
|
|
2017
Q1 | $538K | Hold |
27,852
| – | – | 0.01% | 1049 |
|
|
2016
Q4 | $517K | Sell |
27,852
-37,000
| -57% | -$687K | 0.01% | 1078 |
|
|
2016
Q3 | $909K | Buy |
+64,852
| New | +$909K | 0.01% | 839 |
|